SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001589728-13-000008
Filing Date
2013-11-19
Accepted
2013-11-19 17:08:58
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM10-Q tap09301310q.htm 10-Q 504765
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 9607
3 EXHIBIT 31.1 exhibit321.htm EX-32.1 3168
  Complete submission text file 0001589728-13-000008.txt   4936281

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT tpiv-20130930.xml EX-101.INS 753174
5 XBRL TAXONOMY EXTENSION SCHEMA tpiv-20130930.xsd EX-101.SCH 60461
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tpiv-20130930_cal.xml EX-101.CAL 16595
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tpiv-20130930_lab.xml EX-101.LAB 252468
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tpiv-20130930_pre.xml EX-101.PRE 155899
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tpiv-20130930_def.xml EX-101.DEF 13331
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 131230754
SIC: 2834 Pharmaceutical Preparations